Nektar Therapeutics (NKTR)

[SeriousMoney]

Merrill Lynch to Webcast Nektar Corporate Presentation
February 01, 2006 04:27 PM US Eastern Timezone
http://www.nektar.com/wt/page/investor_relations_

SAN CARLOS, Calif., Feb 01, 2006 (BUSINESS WIRE) -- Nektar Therapeutics (Nasdaq:NKTR) announced today that its corporate presentation will be webcast live from the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference, Wednesday, February 8, 2006 beginning at 9:20 a.m. Eastern Standard Time. The audio-only presentation may be accessed on Nektar's Investor Relations' page at http://www.nektar.com/wt/page/investor_relations_ and will be available within 24 hours following the live presentation until February 15, 2006.

Nektar Therapeutics develops and enables high-value, differentiated therapeutics with its industry-leading drug delivery technologies, expertise and manufacturing capabilities. The world's top biotechnology and pharmaceutical companies are developing new and better therapeutics using Nektar's advanced technologies and know-how. Nektar also develops its own products by applying its drug delivery technologies and its expertise to existing medicines to enhance performance, such as improving efficacy, safety and compliance.

SOURCE: Nektar Therapeutics
http://www.nektar.com/wt/page/Press_Releases?rid=186281